Mundipharma International Limited
Mundipharma International Limited, a prominent player in the global pharmaceutical industry, is headquartered in Great Britain. Founded in 1997, the company has established a strong presence in various operational regions, including Europe, Asia, and the Americas. Specialising in pain management, respiratory care, and other therapeutic areas, Mundipharma is renowned for its innovative products and commitment to improving patient outcomes. The company’s core offerings include unique formulations and delivery systems that set them apart in the market. With a focus on patient-centric solutions, Mundipharma has achieved significant milestones, including strategic partnerships and a robust pipeline of new therapies. Recognised for its dedication to quality and innovation, Mundipharma continues to strengthen its market position, making a meaningful impact in the healthcare landscape.
DitchCarbon Score
How does Mundipharma International Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mundipharma International Limited's score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mundipharma International Limited's reported carbon emissions
Mundipharma International Limited, headquartered in Great Britain, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company is likely aware of the growing importance of climate commitments within the pharmaceutical industry, which is increasingly focused on sustainability and reducing environmental impact. As the industry evolves, Mundipharma may consider establishing measurable climate goals and initiatives to align with global efforts to combat climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mundipharma International Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
